Anthera Pharmaceuticals's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Anthera Pharmaceuticals is scheduled to report earnings on March 5, 2018, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 18	Dec 17	Sep 17	Jun 17	Mar 17
Income Statement	-
Total Revenue	-	-	$ 0.00	$ 0.00	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -4.48M	$ -9.67M	$ -7.91M	$ -8.66M	$ -10.60M
EBITDA	$ -4.32M	$ -9.64M	$ -7.87M	$ -8.50M	$ -10.56M
Net Income Common Stockholders	$ -6.02M	$ -11.28M	$ -6.31M	$ 313.00K	$ -13.71M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 8.09M	$ 2.20M	$ 6.08M	$ 11.15M	$ 20.65M
Total Assets	$ 8.81M	$ 3.67M	$ 8.37M	$ 14.51M	$ 23.59M
Total Debt	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Net Debt	$ -8.09M	$ -2.20M	$ -6.08M	$ -11.15M	$ -20.65M
Total Liabilities	$ 3.35M	$ 9.17M	$ 8.03M	$ 9.95M	$ 21.20M
Stockholders Equity	$ 5.46M	$ -5.50M	$ 343.00K	$ 4.56M	$ 2.39M
Cash Flow	-
Free Cash Flow	$ -9.02M	$ -6.26M	$ -6.20M	$ -10.11M	$ -14.33M
Operating Cash Flow	$ -9.38M	$ -6.26M	$ -6.20M	$ -10.11M	$ -14.33M
Investing Cash Flow	$ 358.00K	-	$ 0.00	$ 0.00	$ 0.00
Financing Cash Flow	$ 14.91M	$ 2.38M	$ 1.12M	$ 612.00K	$ 14.14M

Currency in USD

Anthera Pharmaceuticals Earnings and Revenue History

Income Statement >

Anthera Pharmaceuticals Debt to Assets

Balance Sheet >

Anthera Pharmaceuticals Cash Flow

Cash Flow >

Anthera Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing